Researchers at The University of Texas MD Anderson Cancer Centre say they have discovered a potential oncongene in ovarian cancer, which is the leading cause of gynaecological cancer death in US women.
A portable biosensing device based on micro- and nanotechnologies is expected to help doctors rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
DiagnoSwiss and bioMerieux have signed an exclusive licence agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics.
A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative pain therapy.
Patients suffering from oral cancer have increased levels of certain bacteria in their saliva, according to research published in the Open Access journal, Journal of Translational Medicine. Six common species of bacteria were found at significantly higher levels in the saliva of patients with oral squamous cell carcinoma (OSCC) than in the saliva of healthy individuals. The researchers were able to use three of the six species as a diagnostic tool to predict more than 80% of oral cancer cases. These preliminary findings indicate that three species of bacteria may be incidentally or causally linked with OSCC, and if so detection of these species could be used as a simple, rapid and non-invasive saliva test to diagnose oral cancer.
Using a water droplet 1 trillion times smaller than a litre of soda as a sort of nanoscale test tube, a University of Washington scientist is conducting chemical analysis and experimentation at unprecedented tiny scales.
Physicists in Singapore have created the first paper battery that generates electricity from urine.
The Australian science industry has grown in the last few years. While the progress being made by Australian industries is impressive, there are still many ways in which to improve efficiency and marketability on a global market
Two researchers from Queensland are contributing to a $436 million global plan to improve the health of millions of people in some of the world's poorest countries.
A team of international scientists â€“ including Australians â€“ has made a breakthrough in solving the problem that had put the development of marine-derived pharmaceuticals on hold for years.
Ofru Recycling has introduced a solvent recovery system with the ASC-150 that meets the ATEX European safety standard and contains an integrated steam heating system, rather than the conventional thermal oil heating system.
Researchers at the Howard Hughes Medical Institute in US have provided the first detailed look at the core structure of the abnormal protein filaments found in at least 20 devastating diseases, ranging from Alzheimer's to Creutzfeldt-Jakob disease, the human version of â€œmad cowâ€ disease.
Australian robotics research has received some fresh input as a new partnership between the CSIRO and the MIT computer science and artificial intelligence laboratory in USA has been formed.
University of Toronto researchers have designed a chemical screening tool that will light up when dangerous pathogens and diseases in air, water and bodily fluids are present.
Scientists have developed a genetic tool to help environmental authorities monitor the spread and impact of Australia's most invasive marine species, the New Zealand screwshell.